Influenza Season Articles & Analysis
12 articles found
Welcome to 2023-2024 season’s respiratory surveillance recap, where we’ll share insights from the most recent respiratory surveillance season, covering three major respiratory viruses: COVID-19, influenza, and RSV. ...
Infectious diseases like influenza can be threats to public health and our economy. At the OPTIONS XI for the Control of Influenza conference, leading influenza vaccines provider CSL Seqirus, joined academic, government, research and industry stakeholders to discuss and learn more about influenza and its impact. Below, CSL ...
MADISON, Wis., Sept. 7, 2022 /PRNewswire/ — FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the completion of enrollment of the first cohort in an age de-escalation clinical trial of M2SR (M2 Deficient Single Replication) live virus vaccine, the company’s investigational supra-seasonal ...
School is back in session, here’s what you need to know to help keep your family protected from flu. Influenza can be a real burden. It can spread rapidly between children and their families to have a significant impact on quality of life and disruption of usual activities: resulting in missed school days and for caregivers, missed work and illness themselves. ...
The Southern Hemisphere region includes countries south of the equator such as South Africa, Indonesia, Brazil, Argentina, New Zealand; and Australia – who in particular, has seen dramatic increases in influenza cases. As of July 17, 2022, the National Notifiable Disease Surveillance System reported 204,911 cases of influenza since ...
CSL Seqirus delivered a record 135 million doses of flu vaccines globally last year, here’s how we make such a feat happen. Influenza vaccine manufacturing is an intricate and complex process that culminates in the summer months, when U.S. flu vaccine manufacturers receive regulatory approval from the FDA for the season’s vaccines. ...
” While we don’t know how the upcoming 2022/23 Northern Hemisphere influenza season will unfold, previous activity in the Southern Hemisphere has shed some light on what may be coming our way. For example, the 2017 and 2019 Southern Hemisphere seasons demonstrated high influenza activity, followed by similar high ...
Data published in the Journal of Infectious Diseases demonstrate that M2SR can protect against a multi-seasonal, seven-year drifted influenza strain – MADISON, Wis., Aug. 2, 2021 /PRNewswire/ — FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the publication of ...
Influenza endangers human health for a long time, and seasonal flu causes repeated harm to society and the economy. Every year, about 3 to 5 million people worldwide suffer from severe pneumonia due to seasonal influenza, and the death toll is as high as 250,000 to 500,000. Vaccine is one of the main measures to prevent and ...
‘Protect yourself, your family and our patients from flu this winter’ is the theme for the seasonal influenza campaign this year and with the current uptake of the flu vaccine anecdotally being reported by social care managers as low among their staff, what can you do to drive the uptake of the flu vaccine? ...
Micron has completed a Phase 1 clinical trial of a seasonal influenza vaccine based on its microneedle technology, the results of which were published in the peer-reviewed journal, The Lancet. ...
Abstract Both influenza A and B viruses cause outbreaks of seasonal influenza resulting in significant morbidity and mortality. There are two antigenically distinct lineages of influenza B virus, Yamagata lineage (YL) and Victoria lineage (VL). Since both B lineages have been co-circulating for years, more than 70% of ...